2024 Q2 Form 10-Q Financial Statement

#000165495424006072 Filed on May 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $4.676M $4.679M $4.750M
YoY Change -0.79% -1.49% 11.4%
Cost Of Revenue $2.431M $2.342M $2.320M
YoY Change 4.59% 0.96% 3.56%
Gross Profit $2.244M $2.337M $2.430M
YoY Change -6.02% -3.83% 20.08%
Gross Profit Margin 48.0% 49.95% 51.16%
Selling, General & Admin $1.718M $1.586M $1.677M
YoY Change 7.37% -5.43% 22.87%
% of Gross Profit 76.54% 67.84% 68.99%
Research & Development $787.1K $803.3K $630.1K
YoY Change 15.07% 27.5% 34.04%
% of Gross Profit 35.07% 34.37% 25.93%
Depreciation & Amortization $752.1K $728.7K $628.0K
YoY Change 16.84% 16.03% 28.92%
% of Gross Profit 33.51% 31.18% 25.84%
Operating Expenses $2.505M $2.389M $2.307M
YoY Change 9.68% 3.57% 25.73%
Operating Profit -$260.4K -$51.79K $123.5K
YoY Change -349.79% -141.95% -34.7%
Interest Expense $419.00 -$953.00 -$9.450K
YoY Change 3.71% -89.92% -872.06%
% of Operating Profit -7.65%
Other Income/Expense, Net $9.996K $24.35K -$9.453K
YoY Change -132.8% -357.63% -157.76%
Pretax Income -$250.4K -$27.44K $114.0K
YoY Change -439.41% -124.06% -44.5%
Income Tax -$730.00 -$738.00 -$730.00
% Of Pretax Income -0.64%
Net Earnings -$251.2K -$28.18K $113.3K
YoY Change -443.9% -124.87% -44.65%
Net Earnings / Revenue -5.37% -0.6% 2.39%
Basic Earnings Per Share $0.00 $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 90.48M shares 90.48M shares 90.48M shares
Diluted Shares Outstanding 90.48M shares 90.48M shares 120.7M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $232.7K $244.3K $675.1K
YoY Change -68.55% -63.81% 70.67%
Cash & Equivalents $232.7K $244.3K $675.1K
Short-Term Investments
Other Short-Term Assets $132.2K $118.5K $52.20K
YoY Change 23.69% 126.94% -77.59%
Inventory
Prepaid Expenses $218.6K $218.2K $255.7K
Receivables $1.250M $1.287M $846.9K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.834M $1.868M $1.830M
YoY Change -5.95% 2.06% 25.0%
LONG-TERM ASSETS
Property, Plant & Equipment $261.6K $277.6K $4.378M
YoY Change -94.26% -93.66% 0.19%
Goodwill $110.0K $110.0K $110.0K
YoY Change 0.0% 0.0%
Intangibles $56.57K $59.17K $71.59K
YoY Change -18.73% -17.35%
Long-Term Investments
YoY Change
Other Assets $16.40K $16.56K $20.04K
YoY Change 6.84% -17.37% 23.7%
Total Long-Term Assets $5.570M $5.487M $5.039M
YoY Change 7.95% 8.9% 10.53%
TOTAL ASSETS
Total Short-Term Assets $1.834M $1.868M $1.830M
Total Long-Term Assets $5.570M $5.487M $5.039M
Total Assets $7.404M $7.355M $6.869M
YoY Change 4.14% 7.08% 14.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.532M $2.523M $2.369M
YoY Change 16.4% 6.48% -0.16%
Accrued Expenses $204.7K $204.5K $172.0K
YoY Change 18.19% 18.89% -7.34%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.602M $4.233M $3.637M
YoY Change 18.64% 16.41% 3.5%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $611.6K $707.5K
YoY Change -100.0% -13.56%
Other Long-Term Liabilities $343.6K $414.3K $656.0K
YoY Change -34.18% -36.85% 33.58%
Total Long-Term Liabilities $343.6K $1.026M $1.364M
YoY Change -73.35% -24.76% 177.64%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.602M $4.233M $3.637M
Total Long-Term Liabilities $343.6K $1.026M $1.364M
Total Liabilities $4.946M $5.259M $5.000M
YoY Change -4.3% 5.18% 24.86%
SHAREHOLDERS EQUITY
Retained Earnings -$20.14M -$19.89M -$20.11M
YoY Change 0.52% -1.09% -2.85%
Common Stock $90.48K $90.48K $90.48K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.458M -$888.1K -$1.115M
YoY Change
Total Liabilities & Shareholders Equity $7.404M $7.355M $6.869M
YoY Change 4.14% 7.08% 14.05%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$251.2K -$28.18K $113.3K
YoY Change -443.9% -124.87% -44.65%
Depreciation, Depletion And Amortization $752.1K $728.7K $628.0K
YoY Change 16.84% 16.03% 28.92%
Cash From Operating Activities $874.4K $727.7K $992.4K
YoY Change -0.88% -26.67% 31.08%
INVESTING ACTIVITIES
Capital Expenditures $886.0K $10.09K $28.79K
YoY Change 8.42% -64.95% 115.24%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$886.0K -$825.4K -$795.3K
YoY Change 8.42% 3.79% 28.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $0.00
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities 874.4K $727.7K $992.4K
Cash From Investing Activities -886.0K -$825.4K -$795.3K
Cash From Financing Activities $0.00
Net Change In Cash -11.55K -$97.74K $197.1K
YoY Change -117.76% -149.59% 44.02%
FREE CASH FLOW
Cash From Operating Activities $874.4K $727.7K $992.4K
Capital Expenditures $886.0K $10.09K $28.79K
Free Cash Flow -$11.55K $717.6K $963.6K
YoY Change -117.76% -25.53% 29.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1505807 usd
CY2023Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1095103 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-888057 usd
CY2024Q1 qmci Long Term Portion Of Operating Lease Liability
LongTermPortionOfOperatingLeaseLiability
137841 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
342373 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
808354 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
852514 usd
CY2023Q1 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
866786 usd
CY2023Q1 us-gaap Deferred Revenue
DeferredRevenue
1469261 usd
CY2023Q1 us-gaap Operating Lease Initial Direct Cost Expense Over Term
OperatingLeaseInitialDirectCostExpenseOverTerm
58427 usd
CY2023Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
26987 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-730 usd
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001101433
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Security12b Title
Security12bTitle
Common stock, par value $.001 per share
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
90477798 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
90477798 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
90477798 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
123685 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
123685 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
123685 shares
CY2023Q4 qmci Convertible Preferred Stock Designated
ConvertiblePreferredStockDesignated
550000 shares
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
0-28599
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
QuoteMedia, Inc.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
91-2008633
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
17100 East Shea Boulevard
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 230
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Fountain Hills
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85268
CY2024Q1 dei City Area Code
CityAreaCode
602
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
830-1443
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
90477798 shares
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
244277 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
342014 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1286609 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1154787 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
218199 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
133478 usd
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
118451 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
104931 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
1867536 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1735210 usd
CY2024Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
16558 usd
CY2023Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
16850 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
277590 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
302224 usd
CY2024Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
4680740 usd
CY2023Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
4552910 usd
CY2024Q1 us-gaap Goodwill
Goodwill
110000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
110000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
59166 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
65636 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
343369 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
393472 usd
CY2024Q1 us-gaap Assets
Assets
7354959 usd
CY2023Q4 us-gaap Assets
Assets
7176302 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2522960 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2210933 usd
CY2024Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1505807 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1456381 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
204532 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
206146 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4233299 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3873460 usd
CY2024Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
276456 usd
CY2023Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
375568 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
137841 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
191735 usd
CY2024Q1 qmci Preferred Stock Warrant Liability
PreferredStockWarrantLiability
611563 usd
CY2023Q4 qmci Preferred Stock Warrant Liability
PreferredStockWarrantLiability
611563 usd
CY2024Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1025860 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1178866 usd
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 qmci Convertible Preferred Stock Designated
ConvertiblePreferredStockDesignated
550000 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
123685 shares
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
2983857 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
2983857 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
90477798 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
90479 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
90479 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18910482 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18910482 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19889018 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19860842 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-859881 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7354959 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7176302 usd
CY2024Q1 us-gaap Revenues
Revenues
4679200 usd
CY2023Q1 us-gaap Revenues
Revenues
4750048 usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
2342114 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
2319935 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
2337086 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
2430113 usd
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
777202 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
824053 usd
CY2024Q1 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
803322 usd
CY2023Q1 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
630073 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
2388878 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
2306640 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-51792 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
123473 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
25307 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-8001 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
-953 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
-1452 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
24354 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9453 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-27438 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
114020 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-738 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-28176 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
113290 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90477798 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90477798 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
90477798 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
120743864 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-859881 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-28176 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-888057 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1228675 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
113290 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1115385 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-28176 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
113290 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
728678 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
627987 usd
CY2024Q1 qmci Allowance For Doubtful Accounts
AllowanceForDoubtfulAccounts
225000 usd
CY2023Q1 qmci Allowance For Doubtful Accounts
AllowanceForDoubtfulAccounts
200000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
78125 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-356822 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-136666 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-84721 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-23958 usd
CY2024Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-13520 usd
CY2023Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-23104 usd
CY2024Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
292 usd
CY2023Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
-5042 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
306622 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-140666 usd
CY2024Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-49686 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
302413 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
727667 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
992379 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10089 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28786 usd
CY2024Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
815315 usd
CY2023Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
766515 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-825404 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-795301 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-97737 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
197078 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
342014 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
477987 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
244277 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
675065 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
225000 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
13329 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-64093 usd
CY2024Q1 us-gaap Revenues
Revenues
4679200 usd
CY2023Q1 us-gaap Revenues
Revenues
4750048 usd
CY2024Q1 qmci Deferred Revenue At Beginning Balance
DeferredRevenueAtBeginningBalance
1831949 usd
CY2023Q1 qmci Deferred Revenue At Beginning Balance
DeferredRevenueAtBeginningBalance
1166848 usd
CY2024Q1 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
681276 usd
CY2023Q1 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
565370 usd
CY2024Q1 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
624920 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
6670 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
997 usd
CY2024Q1 qmci Deferred Revenue At Ending Balance
DeferredRevenueAtEndingBalance
1782263 usd
CY2023Q1 qmci Deferred Revenue At Ending Balance
DeferredRevenueAtEndingBalance
1469261 usd
CY2024Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
276456 usd
CY2023Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
374158 usd
CY2024Q1 us-gaap Deferred Revenue
DeferredRevenue
1782263 usd
CY2024Q1 us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
1 year to 3 years
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
343369 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
393472 usd
CY2024Q1 qmci Current Portion Of Operating Lease Liability
CurrentPortionOfOperatingLeaseLiability
204532 usd
CY2023Q4 qmci Current Portion Of Operating Lease Liability
CurrentPortionOfOperatingLeaseLiability
206146 usd
CY2023Q4 qmci Long Term Portion Of Operating Lease Liability
LongTermPortionOfOperatingLeaseLiability
191735 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
397881 usd
CY2024Q1 qmci Operating Lease Weighted Average Remaining Lease Term
OperatingLeaseWeightedAverageRemainingLeaseTerm
P1Y8M12D
CY2023 qmci Operating Lease Weighted Average Remaining Lease Term
OperatingLeaseWeightedAverageRemainingLeaseTerm
P1Y10M24D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.095 pure
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.095 pure
CY2024Q1 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
173176 usd
CY2024Q1 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
164773 usd
CY2024Q1 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
34074 usd
CY2024Q1 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
372023 usd
CY2024Q1 qmci Less Imputed Interest Operating
LessImputedInterestOperating
-29650 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
342373 usd
CY2024Q1 us-gaap Operating Lease Initial Direct Cost Expense Over Term
OperatingLeaseInitialDirectCostExpenseOverTerm
59041 usd
CY2024Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
27336 usd
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
86377 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
85414 usd
CY2024Q1 qmci Operating Cash Flows From Operating Leases
OperatingCashFlowsFromOperatingLeases
57814 usd
CY2023Q1 qmci Operating Cash Flows From Operating Leases
OperatingCashFlowsFromOperatingLeases
56719 usd
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4239 usd
CY2024Q1 qmci Expected Time To Expiration Years
ExpectedTimeToExpirationYears
P24Y18D
CY2023 qmci Expected Time To Expiration Years
ExpectedTimeToExpirationYears
P24Y18D
CY2024Q1 qmci Stock Price On Valuation Date
StockPriceOnValuationDate
0.23
CY2023 qmci Stock Price On Valuation Date
StockPriceOnValuationDate
0.23
CY2024Q1 qmci Five Year Peer Volatility
FiveYearPeerVolatility
0.4735 pure
CY2023 qmci Five Year Peer Volatility
FiveYearPeerVolatility
0.4735 pure
CY2024Q1 qmci Cash Flow Discount Rate
CashFlowDiscountRate
0.1586 pure
CY2023 qmci Cash Flow Discount Rate
CashFlowDiscountRate
0.1586 pure
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-28176 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
113290 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90477798 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90477798 shares
CY2024Q1 qmci Warrants To Purchase Redeemable Convertible Preferred Stock
WarrantsToPurchaseRedeemableConvertiblePreferredStock
0 usd
CY2023Q1 qmci Warrants To Purchase Redeemable Convertible Preferred Stock
WarrantsToPurchaseRedeemableConvertiblePreferredStock
2499900 usd
CY2024Q1 qmci Redeemable Convertible Preferred Stock
RedeemableConvertiblePreferredStock
0 usd
CY2023Q1 qmci Redeemable Convertible Preferred Stock
RedeemableConvertiblePreferredStock
10306671 usd
CY2023Q1 qmci Stock Options And Warrants To Purchase Common Stock
StockOptionsAndWarrantsToPurchaseCommonStock
17459495 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
90477798 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
120743864 shares
CY2024Q1 qmci Earningspersharebasic
Earningspersharebasic
-0.00
CY2023Q1 qmci Earningspersharebasic
Earningspersharebasic
0.00
CY2024Q1 qmci Earningspersharediluted
Earningspersharediluted
-0.00
CY2023Q1 qmci Earningspersharediluted
Earningspersharediluted
0.00
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
29527212 shares

Files In Submission

Name View Source Status
0001654954-24-006072-index-headers.html Edgar Link pending
0001654954-24-006072-index.html Edgar Link pending
0001654954-24-006072.txt Edgar Link pending
0001654954-24-006072-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
qmci-20240331.xsd Edgar Link pending
qmci_10q.htm Edgar Link pending
qmci_ex311.htm Edgar Link pending
qmci_ex312.htm Edgar Link pending
qmci_ex321.htm Edgar Link pending
qmci_ex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
qmci-20240331_cal.xml Edgar Link unprocessable
qmci-20240331_def.xml Edgar Link unprocessable
qmci-20240331_lab.xml Edgar Link unprocessable
qmci-20240331_pre.xml Edgar Link unprocessable
qmci_10q_htm.xml Edgar Link completed
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable